Understanding nuclear receptor form and function using structural biology

Journal of Molecular Endocrinology

Volumn 51, Issue 3, 2013, Pages

  Rastinejad, Fraydoon ^a   Huang, Pengxiang ^a   Chandra, Vikas ^a   Khorasanizadeh, Sepideh ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Gene regulation; Metabolism; Nuclear receptors; Steroid hormones; Transcription factors

Indexed keywords

CELL NUCLEUS RECEPTOR; CYSTEINE; DEXAMETHASONE; DNA; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MIFEPRISTONE; PROGESTERONE RECEPTOR; RETINOID X RECEPTOR ALPHA; TAMOXIFEN; ZINC ION;

CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DNA BINDING; HUMAN; LIGAND BINDING; LIPOPHILICITY; MOLECULAR RECOGNITION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA INTERACTION; PROTEIN QUATERNARY STRUCTURE; REVIEW; STRUCTURAL GENOMICS;

GENE REGULATION; METABOLISM; NUCLEAR RECEPTORS; STEROID HORMONES; TRANSCRIPTION FACTORS;

ANIMALS; HEPATOCYTE NUCLEAR FACTORS; HUMANS; PPAR GAMMA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTORS;

EID: 84887357178     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0173     Document Type: Review

References (131)

1. Bartoov-Shifman R, Hertz R, Wang H, Wollheim CB, Bar-Tana J & Walker M. D 2002 Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4a. Journal of Biological Chemistry 277 25914-25919. (doi:10.1074/jbc.M201582200)
2. Baxter J. D & Webb P 2009 Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nature Reviews. Drug Discovery 8 308-320. (doi:10.1038/nrd2830)
3. Biggadike K., Bledsoe RK, Hassell AM, Kirk BE, McLay IM, Shewchuk LM & Stewart E. L 2008 X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. Journal of Medicinal Chemistry 51 3349-3352. (doi:10.1021/jm800279t)
4. Bledsoe R. K, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler T. G, Parks DJ, Stewart EL, Willson TM et al. 2002 Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 93-105. (doi:10.1016/S0092-8674(02)00817-6)
5. Bolotin E., Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T & Sladek F. M 2010 Integrated approach for the identification of human hepatocyte nuclear factor 4a target genes using protein binding microarrays. Hepatology 51 642-653. (doi:10.1002/hep.23357)
6. Bourguet W., Ruff M, Chambon P, Gronemeyer H & Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-a. Nature 375 377-382. (doi:10.1038/375377a0)
7. Bruning J. B, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y, Nettles K. W & Griffin PR 2007 Partial agonists activate PPARg using a helix 12 independent mechanism. Structure 15 1258-1271. (doi:10.1016/j.str.2007.07.014)
8. Brzozowski A. M, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L., Greene GL, Gustafsson JA & Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 753-758. (doi:10.1038/39645)
9. Bugge T. H, Pohl J, Lonnoy O & Stunnenberg HG 1992 RXRa, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO Journal 11 1409-1418.
10. Chandra V., Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP & Rastinejad F. 2008 Structure of the intact PPAR-g-RXR-a nuclear receptor complex on DNA. Nature 456 350-356. (doi:10.1038/ nature07413)
11. Chandra V., Huang P, Potluri N, Wu D, Kim Y & Rastinejad F 2013 Multidomain integration in the structure of the HNF-4a nuclear receptor complex. Nature 495 394-398. (doi:10.1038/nature11966)
12. Charles J. P, Shinoda T & Chinzei Y 1999 Characterization and DNA-binding properties of GRF, a novel monomeric binding orphan receptor related to GCNF and bFTZ-F1. European Journal of Biochemistry 266 181-190. (doi:10.1046/j.1432-1327.1999.00842.x)
13. Clegg N. J, Wongvipat J, Joseph JD, TranC, Ouk S, Dilhas A, Chen Y, Grillot K, Bischoff E. D, Cai L et al. 2012 ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Research 72 1494-1503. (doi:10.1158/0008-5472.CAN-11-3948)
14. Dai S. Y, Burris TP, Dodge JA, Montrose-Rafizadeh C, Wang Y, Pascal BD, Chalmers M. J & Griffin PR 2009 Unique ligand binding patterns between estrogen receptor a and b revealed by hydrogen-deuterium exchange. Biochemistry 48 9668-9676. (doi:10.1021/bi901149t)
15. Darimont B. D, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick R. J & Yamamoto KR 1998 Structure and specificity of nuclear receptor-coactivator interactions. Genes and Development 12 3343-3356. (doi:10.1101/gad.12.21.3343)
16. Deroo B. J & Korach KS 2006 Estrogen receptors and human disease. Journal of Clinical Investigation 116 561-570. (doi:10.1172/JCI27987)
17. Devarakonda S., Harp JM, Kim Y, Ozyhar A & Rastinejad F 2003 Structure of the heterodimeric ecdysone receptor DNA-binding complex. EMBO Journal 22 5827-5840. (doi:10.1093/emboj/cdg569)
18. Devarakonda S., Gupta K, Chalmers MJ, Hunt JF, Griffin PR, Van Duyne GD & Spiegelman BM 2011 Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active PGC-1a/ERRg complex. PNAS 108 18678-18683. (doi:10.1073/pnas. 1113813108)
19. Fang B., Mane-Padros D, Bolotin E, Jiang T & Sladek FM 2012 Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Nucleic Acids Research 40 5343-5356. (doi:10.1093/ nar/gks190)
20. Forman B. M, Umesono K, Chen J & Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81 541-550. (doi:10.1016/0092-8674 (95)90075-6)
21. Freedman L. P, Luisi BF, Korszun ZR, Basavappa R, Sigler PB & Yamamoto KR 1988 The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334 543-546. (doi:10.1038/334543a0)
22. Germain P., Iyer J, Zechel C & Gronemeyer H 2002 Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415 187-192. (doi:10.1038/415187a)
23. Germain P., Kammerer S, Perez E, Peluso-Iltis C, Tortolani D, Zusi FC, Starrett J., Lapointe P, Daris JP, Marinier A et al. 2004 Rational design of RAR-selective ligands revealed by RARb crystal structure. EMBO Reports 5 877-882. (doi:10.1038/sj.embor.7400235)
24. Giguere V., McBroom LD & Flock G 1995 Determinants of target gene specificity for RORa1: monomeric DNA binding by an orphan nuclear receptor. Molecular and Cellular Biology 15 2517-2526.
25. Glass C. K&RosenfeldMG2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes and Development 14 121-141. (doi:10.1101/gad.14.2.121)
26. Green S. & Chambon P 1987 Oestradiol induction of a glucocorticoidresponsive gene by a chimaeric receptor. Nature 325 75-78. (doi:10.1038/325075a0)
27. Greschik H., Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, Moras D & Renaud J. P 2002 Structural and functional evidence for ligandindependent transcriptional activation by the estrogen-related receptor 3. Molecular Cell 9 303-313. (doi:10.1016/S1097-2765(02)00444-6)
28. Gronemeyer H., Gustafsson JA & Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nature Reviews. Drug Discovery 3 950-964. (doi:10.1038/nrd1551)
29. Gustafsson J. A 2003 What pharmacologists can learn from recent advances in estrogen signalling. Trends in Pharmacological Sciences 24 479-485. (doi:10.1016/S0165-6147(03)00229-3)
30. Hall J. M, McDonnell DP & Korach KS 2002 Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Molecular Endocrinology 16 469-486. (doi:10.1210/me.16.3.469)
31. Hallenbeck P. L, Marks MS, Lippoldt RE, Ozato K & Nikodem VM 1992 Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXRb) enhances DNA binding and TH-dependent transcriptional activation. PNAS 89 5572-5576. (doi:10.1073/pnas.89.12.5572)
32. Hard T., Kellenbach E, Boelens R, Maler BA, Dahlman K, Freedman LP, Carlstedt-Duke J, Yamamoto KR, Gustafsson JA & Kaptein R 1990 Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249 157-160. (doi:10.1126/science.2115209)
33. Harding H. P & Lazar MA 1995 The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Molecular and Cellular Biology 15 4791-4802.
34. He B., Kemppainen JA & Wilson EM 2000 FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. Journal of Biological Chemistry 275 22986-22994. (doi:10.1074/jbc.M002807200)
35. Heery D. M, Kalkhoven E, Hoare S & Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 733-736. (doi:10.1038/42750)
36. Helsen C., Dubois V, Verfaillie A, Young J, Trekels M, Vancraenenbroeck R, De Maeyer M & Claessens F 2012 Evidence for DNA-binding domain-ligand-binding domain communications in the androgen receptor. Molecular and Cellular Biology 32 3033-3043. (doi:10.1128/MCB.00151-12)
37. Hu X. & Lazar MA 1999 The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402 93-96. (doi:10.1038/47069)
38. Huang P., Chandra V & Rastinejad F 2010 Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annual Review of Physiology 72 247-272. (doi:10.1146/annurevphysiol-021909-135917)
39. Hughes T. S, ChalmersMJ, Novick S, Kuruvilla DS, ChangMR, KameneckaTM, Rance M., Johnson BA, Burris TP, Griffin PR et al. 2012 Ligand and receptor dynamics contribute to the mechanism of graded PPARg agonism. Structure 20 139-150. (doi:10.1016/j.str.2011.10.018)
40. Huh J. R, Leung MW, Huang P, Ryan DA, Krout MR, Malapaka RR, Chow J, Manel N., Ciofani M, Kim SV et al. 2011 Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgt activity. Nature 472 486-490. (doi:10.1038/nature09978)
41. Johnson B. A, Wilson EM, Li Y, Moller DE, Smith RG & Zhou G 2000 Ligand-induced stabilization of PPARg monitored by NMR spectroscopy: implications for nuclear receptor activation. Journal of Molecular Biology 298 187-194. (doi:10.1006/jmbi.2000.3636)
42. Kallenberger B. C, Love JD, Chatterjee VK & Schwabe JW 2003 A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nature Structural Biology 10 136-140. (doi:10.1038/ nsb892)
43. Kapoor R. R, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, Ellard S & Hussain K. 2008 Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 57 1659-1663. (doi:10.2337/db07-1657)
44. Kauppi B., Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O., Harlan J, Muchmore S et al. 2003 The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. Journal of Biological Chemistry 278 22748-22754. (doi:10.1074/jbc.M212711200)
45. Keidel S., LeMotte P & Apfel C 1994 Different agonist-and antagonistinduced conformational changes in retinoic acid receptors analyzed by protease mapping. Molecular and Cellular Biology 14 287-298.
46. Khorasanizadeh S. & Rastinejad F 2001 Nuclear-receptor interactions on DNA-response elements. Trends in Biochemical Sciences 26 384-390. (doi:10.1016/S0968-0004(01)01800-X)
47. Kliewer S. A, Umesono K, Mangelsdorf DJ & Evans RM 1992a Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355 446-449. (doi:10.1038/355446a0)
48. Kliewer S. A, Umesono K, Noonan DJ, Heyman RA & Evans RM 1992b Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 771-774. (doi:10.1038/358771a0)
49. Knegtel R. M, Katahira M, Schilthuis JG, Bonvin AM, Boelens R, Eib D, van der Saag PT & Kaptein R 1993 The solution structure of the human retinoic acid receptor-b DNA-binding domain. Journal of Biomolecular NMR 3 1-17. (doi:10.1007/BF00242472)
50. Kruse S. W, Suino-Powell K, Zhou XE, Kretschman JE, Reynolds R, Vonrhein C., Xu Y, Wang L, Tsai SY, Tsai MJ et al. 2008 Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biology 6 e227. (doi:10.1371/journal.pbio.0060227)
51. Krylova I. N, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum J. M, Madauss K, Montana V et al. 2005 Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120 343-355. (doi:10.1016/j.cell.2005.01.024)
52. Kumar V., Green S, Stack G, Berry M, Jin JR & Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51 941-951. (doi:10.1016/0092-8674(87)90581-2)
53. Kurokawa R., DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman R. A & Glass CK 1994 Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371 528-531. (doi:10.1038/371528a0)
54. Lefstin J. A & Yamamoto KR 1998 Allosteric effects of DNA on transcriptional regulators. Nature 392 885-888. (doi:10.1038/31860)
55. Lefstin J. A, Thomas JR & Yamamoto KR 1994 Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes and Development 8 2842-2856. (doi:10.1101/gad.8.23.2842)
56. Leid M., Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen J. Y, Staub A, Garnier JM, Mader S et al. 1992 Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68 377-395. (doi:10.1016/0092-8674(92)90478-U)
57. Leitman D. C, Paruthiyil S, Vivar OI, Saunier EF, Herber CB, Cohen I, Tagliaferri M. & Speed TP 2010 Regulation of specific target genes and biological responses by estrogen receptor subtype agonists. Current Opinion in Pharmacology 10 629-636. (doi:10.1016/j.coph.2010.09.009)
58. Leng X., Tsai SY, O'Malley BW & Tsai MJ 1993 Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. Journal of Steroid Biochemistry and Molecular Biology 46 643-661. (doi:10.1016/0960-0760(93)90306-H)
59. Li Y., Lambert MH & Xu HE 2003 Activation of nuclear receptors: a perspective from structural genomics. Structure 11 741-746. (doi:10.1016/S0969-2126(03)00133-3)
60. Little T. H, Zhang Y, Matulis CK, Weck J, Zhang Z, Ramachandran A, Mayo KE &Radhakrishnan I 2006 Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of the DNA binding domain is necessary for complex stability. Molecular Endocrinology 20 831-843. (doi:10.1210/me.2005-0384)
61. Lu P., Rha GB, Melikishvili M, Wu G, Adkins BC, Fried MG & Chi YI 2008 Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4a. Diabetes gene product. Journal of Biological Chemistry 283 33685-33697. (doi:10.1074/jbc.M806213200)
62. Luisi B. F, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR & Sigler PB 1991 Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 497-505. (doi:10.1038/352497a0)
63. Mader S., Chen JY, Chen Z, White J, Chambon P & Gronemeyer H 1993 The patterns of binding of RAR, RXR and TR homo-and heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. EMBO Journal 12 5029-5041.
64. Mak H. Y, Hoare S, Henttu PM & Parker MG 1999 Molecular determinants of the estrogen receptor-coactivator interface. Molecular and Cellular Biology 19 3895-3903.
65. Manas E. S, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T., Hum WT, Malakian K et al. 2004 Structure-based design of estrogen receptor-b selective ligands. Journal of the American Chemical Society 126 15106-15119. (doi:10.1021/ja047633o)
66. Mangelsdorf D. J & Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83 841-850. (doi:10.1016/0092-8674(95)90200-7)
67. Mangelsdorf D. J, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B., Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839. (doi:10.1016/0092-8674(95)90199-X)
68. Marks M. S, Hallenbeck PL, Nagata T, Segars JH, Appella E, Nikodem VM & Ozato K. 1992 H-2RIIBP (RXRb) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO Journal 11 1419-1435.
69. McKenna NJ, Lanz RB & O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocrine Reviews 20 321-344. (doi:10.1210/er.20.3.321)
70. Meijsing S. H, Pufall MA, So AY, Bates DL, Chen L & Yamamoto KR 2009 DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324 407-410. (doi:10.1126/science.1164265)
71. Meinke G. & Sigler PB 1999 DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B. Nature Structural Biology 6 471-477. (doi:10.1038/8276)
72. Mi L. Z, Devarakonda S, Harp JM, Han Q, Pellicciari R, Willson TM, Khorasanizadeh S. & Rastinejad F 2003 Structural basis for bile acid binding and activation of the nuclear receptor FXR. Molecular Cell 11 1093-1100. (doi:10.1016/S1097-2765(03)00112-6)
73. Mukherjee R., Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, Hamann L. G, Boehm MF, Mondon CE, Nadzan AM et al. 1997 Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386 407-410. (doi:10.1038/386407a0)
74. Nagy L. & Schwabe JW 2004 Mechanism of the nuclear receptor molecular switch. Trends in Biochemical Sciences 29 317-324. (doi:10.1016/j.tibs. 2004.04.006)
75. Nelson C. C, Hendy SC, Shukin RJ, Cheng H, Bruchovsky N, Koop BF & Rennie P. S 1999 Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Molecular Endocrinology 13 2090-2107. (doi:10.1210/me.13.12.2090)
76. Nilsson S., Koehler KF & Gustafsson JA 2011 Development of subtypeselective oestrogen receptor-based therapeutics. Nature Reviews. Drug Discovery 10 778-792. (doi:10.1038/nrd3551)
77. Nolte R. T, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld M. G, Willson TM, Glass CK & Milburn MV 1998 Ligand binding and co-activator assembly of the peroxisome proliferatoractivated receptor-g. Nature 395 137-143. (doi:10.1038/25931)
78. Orlov I., Rochel N, Moras D & Klaholz BP 2012 Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. EMBO Journal 31 291-300. (doi:10.1038/emboj.2011.445)
79. Ottow E. &Weinmann H 2008 Nuclear Receptors as Drug Targets. Weinheim, Germany: Wiley-VCH.
80. Pardee K. I, XuX, Reinking J, Schuetz A, Dong A, Liu S, Zhang R, Tiefenbach J, Lajoie G., Plotnikov AN et al. 2009 The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBb. PLoS Biology 7 e43. (doi:10.1371/journal.pbio.1000043)
81. Perlmann T., Rangarajan PN, Umesono K & Evans RM 1993 Determinants for selective RAR and TR recognition of direct repeat HREs. Genes and Development 7 1411-1422. (doi:10.1101/gad.7.7b.1411)
82. Phelan C. A, Gampe RT Jr, Lambert MH, Parks DJ, Montana V, Bynum J, Broderick T. M, Hu X, Williams SP, Nolte RT et al. 2010 Structure of Rev-erba bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction. Nature Structural & Molecular Biology 17 808-814. (doi:10.1038/nsmb.1860)
83. Pike A. C, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J., Gustafsson JA & Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor b in the presence of a partial agonist and a full antagonist. EMBO Journal 18 4608-4618. (doi:10.1093/emboj/18.17.4608)
84. Pike A. C, Brzozowski AM, Walton J, Hubbard RE, Bonn T, Gustafsson JA & Carlquist M. 2000 Structural aspects of agonism and antagonism in the oestrogen receptor. Biochemical Society Transactions 28 396-400. (doi:10.1042/0300-5127:0280396)
85. Pike A. C, Brzozowski AM, Walton J, Hubbard RE, Thorsell AG, Li YL, Gustafsson J. A & Carlquist M 2001 Structural insights into the mode of action of a pure antiestrogen. Structure 9 145-153. (doi:10.1016/ S0969-2126(01)00568-8)
86. Pissios P., Tzameli I, Kushner P & Moore DD 2000 Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding. Molecular Cell 6 245-253. (doi:10.1016/ S1097-2765(00)00026-5)
87. Raghuram S., Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, Burris L. L, Khorasanizadeh S, Burris TP & Rastinejad F 2007 Identification of heme as the ligand for the orphan nuclear receptors REV-ERBa and REV-ERBb. Nature Structural & Molecular Biology 14 1207-1213. (doi:10.1038/nsmb1344)
88. Rastinejad F., Perlmann T, Evans RM & Sigler PB 1995 Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375 203-211. (doi:10.1038/375203a0)
89. Rastinejad F., Wagner T, Zhao Q & Khorasanizadeh S 2000 Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO Journal 19 1045-1054. (doi:10.1093/emboj/19.5.1045)
90. Renaud J. P, Rochel N, Ruff M, Vivat V, Chambon P, GronemeyerH&Moras D 1995 Crystal structure of the RAR-g ligand-binding domain bound to all-trans retinoic acid. Nature 378 681-689. (doi:10.1038/378681a0)
91. Rochel N., Ciesielski F, Godet J, Moman E, Roessle M, Peluso-Iltis C, Moulin M., Haertlein M, Callow P, Mely Y et al. 2011 Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nature Structural & Molecular Biology 18 564-570. (doi:10.1038/nsmb.2054)
92. Roemer S. C, Donham DC, Sherman L, Pon VH, Edwards DP & Churchill ME 2006 Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Molecular Endocrinology 20 3042-3052. (doi:10.1210/me. 2005-0511)
93. Ryffel G. U 2001 Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. Journal of Molecular Endocrinology 27 11-29. (doi:10.1677/jme.0.0270011)
94. Sablin E. P, Krylova IN, Fletterick RJ & Ingraham HA 2003 Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Molecular Cell 11 1575-1585. (doi:10.1016/S1097-2765(03)00236-3)
95. Schwabe J. W, Neuhaus D & Rhodes D 1990 Solution structure of the DNAbinding domain of the oestrogen receptor. Nature 348 458-461. (doi:10.1038/348458a0)
96. Schwabe J. W, Chapman L, Finch JT & Rhodes D 1993 The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75 567-578. (doi:10.1016/0092-8674(93)90390-C)
97. Shaffer P. L & Gewirth DT 2002 Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO Journal 21 2242-2252. (doi:10.1093/emboj/21.9.2242)
98. Shaffer P. L, Jivan A, Dollins DE, Claessens F & Gewirth DT 2004 Structural basis of androgen receptor binding to selective androgen response elements. PNAS 101 4758-4763. (doi:10.1073/pnas.0401123101)
99. Shiau A. K, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA & Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 927-937. (doi:10.1016/S0092-8674(00)81717-1)
100. Sierk M. L, Zhao Q & Rastinejad F 2001 DNA deformability as a recognition feature in the reverb response element. Biochemistry 40 12833-12843. (doi:10.1021/bi011086r)
101. Sierra M. L, Beneton V, Boullay AB, Boyer T, Brewster AG, Donche F, Forest M. C, Fouchet MH, Gellibert FJ, Grillot DA et al. 2007 Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARa agonists. 1. Discovery of a novel series of potent HDLc raising agents. Journal of Medicinal Chemistry 50 685-695. (doi:10.1021/ jm058056x)
102. Sladek F. M, Zhong WM, Lai E & Darnell JE Jr 1990 Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes and Development 4 2353-2365. (doi:10.1101/gad.4.12b.2353)
103. Solomon I. H, Hager JM, Safi R, McDonnell DP, Redinbo MR & Ortlund EA 2005 Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. Journal of Molecular Biology 354 1091-1102. (doi:10.1016/j.jmb.2005.10.009)
104. Stauffer S. R, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen B. S & Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptora-selective agonists. Journal of Medicinal Chemistry 43 4934-4947. (doi:10.1021/jm000170m)
105. Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud J. P, Moras D & Schule R 2003 All-trans retinoic acid is a ligand for the orphan nuclear receptor RORb. Nature Structural Biology 10 820-825. (doi:10.1038/nsb979)
106. Sun J., Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA & Katzenellenbogen B. S 1999 Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-a or estrogen receptor-b. Endocrinology 140 800-804. (doi:10.1210/en.140.2.800)
107. Sun J., Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA & Katzenellenbogen B. S 2002 Antagonists selective for estrogen receptor a. Endocrinology 143 941-947. (doi:10.1210/en.143.3.941)
108. Sun J., Baudry J, Katzenellenbogen JA & Katzenellenbogen BS 2003 Molecular basis for the subtype discrimination of the estrogen receptor-b-selective ligand, diarylpropionitrile. Molecular Endocrinology 17 247-258. (doi:10.1210/me.2002-0341)
109. Takacs M., Petoukhov MV, Atkinson RA, Roblin P, Ogi FX, Demeler B, Potier N., Chebaro Y, Dejaegere A, Svergun DI et al. 2013 The asymmetric binding of PGC-1a to the ERRa and ERRg nuclear receptor homodimers involves a similar recognition mechanism. PLoS ONE 8 e67810. (doi:10.1371/journal.pone.0067810)
110. Tanenbaum D. M, Wang Y, Williams SP & Sigler PB 1998 Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. PNAS 95 5998-6003. (doi:10.1073/pnas.95.11.5998)
111. Umesono K. & Evans RM 1989 Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57 1139-1146. (doi:10.1016/ 0092-8674(89)90051-2)
112. Umesono K, Murakami KK, Thompson CC & Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65 1255-1266. (doi:10.1016/0092-8674(91)90020-Y)
113. Wagner R. L, Huber BR, Shiau AK, Kelly A, Cunha Lima ST, Scanlan TS, Apriletti J. W, Baxter JD, West BL & Fletterick RJ 2001 Hormone selectivity in thyroid hormone receptors. Molecular Endocrinology 15 398-410. (doi:10.1210/me.15.3.398)
114. Wang Z., Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, Xu H, Walker NP & Perlmann T. 2003 Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423 555-560. (doi:10.1038/nature01645)
115. Watkins R. E, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert M. H, Kliewer SA & Redinbo MR 2003 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42 1430-1438. (doi:10.1021/bi0268753)
116. Watson L. C, Kuchenbecker KM, Schiller BJ, Gross JD, Pufall MA & Yamamoto K. R 2013 The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals. Nature Structural & Molecular Biology 20 876-883. (doi:10.1038/nsmb.2595)
117. Williams S., Bledsoe RK, Collins JL, Boggs S, Lambert MH, Miller AB, Moore J, McKee DD, Moore L, Nichols J et al. 2003 X-ray crystal structure of the liver X receptor b ligand binding domain: regulation by a histidine-tryptophan switch. Journal of Biological Chemistry 278 27138-27143. (doi:10.1074/jbc.M302260200)
118. Wilson T. E, Fahrner TJ & Milbrandt J 1993 The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Molecular and Cellular Biology 13 5794-5804.
119. Wurtz J. M, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D & Gronemeyer H. 1996 A canonical structure for the ligand-binding domain of nuclear receptors. Nature Structural Biology 3 87-94. (doi:10.1038/nsb0196-87)
120. Xu H. E, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT et al. 2002 Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARa. Nature 415 813-817. (doi:10.1038/415813a)
121. Yin L., Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, Waitt GM, Parks D. J, Pearce KH, Wisely GB et al. 2007 Rev-erba, a heme sensor that coordinates metabolic and circadian pathways. Science 318 1786-1789. (doi:10.1126/science.1150179)
122. Yin L, Ma H, Ge X, Edwards PA & Zhang Y 2011 Hepatic hepatocyte nuclear factor 4a is essential for maintaining triglyceride and cholesterol homeostasis. Arteriosclerosis, Thrombosis, and Vascular Biology 31 328-336. (doi:10.1161/ATVBAHA.110.217828)
123. Yoon J. C, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J., Kahn CR, Granner DK et al. 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 131-138. (doi:10.1038/35093050)
124. Yu V. C, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J. M, Glass CK, Rosenfeld MG et al. 1991 RXRb: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67 1251-1266. (doi:10.1016/0092-8674(91)90301-E)
125. Zechel C., Shen XQ, Chambon P & Gronemeyer H 1994a Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO Journal 13 1414-1424.
126. Zechel C., Shen XQ, Chen JY, Chen ZP, Chambon P & Gronemeyer H 1994b The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO Journal 13 1425-1433.
127. Zhang J., Chalmers MJ, Stayrook KR, Burris LL, Garcia-Ordonez RD, Pascal B. D, Burris TP, Dodge JA & Griffin PR 2010 Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer. Structure 18 1332-1341. (doi:10.1016/j.str.2010.07.007)
128. Zhang J., Chalmers MJ, Stayrook KR, Burris LL, Wang Y, Busby SA, Pascal BD, Garcia-Ordonez RD, Bruning JB, Istrate MA et al. 2011 DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nature Structural & Molecular Biology 18 556-563. (doi:10.1038/ nsmb.2046)
129. Zhao Q., Khorasanizadeh S, Miyoshi Y, Lazar MA & Rastinejad F 1998 Structural elements of an orphan nuclear receptor-DNA complex. Molecular Cell 1 849-861. (doi:10.1016/S1097-2765(00)80084-2)
130. Zhao Q., Chasse SA, Devarakonda S, Sierk ML, Ahvazi B & Rastinejad F 2000 Structural basis of RXR-DNA interactions. Journal of Molecular Biology 296 509-520. (doi:10.1006/jmbi.1999.3457)
131. Zhou X. E, Suino-Powell KM, Xu Y, Chan CW, Tanabe O, Kruse SW, Reynolds R., Engel JD & Xu HE 2011 The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor. Journal of Biological Chemistry 286 2877-2885. (doi:10.1074/jbc.M110.168740)